, Sanofi, Bridgewater, NJ, United States

• Archivio Italiano di Urologia e Andrologia Vol. 88 No. 1 (2016) - Letters to the Editor
  Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
  Abstract  PDF